ОЗВУЧИТЬ

From genome to regenerative medicine: which technologies determine the future of Russian medicine

During the session "Biotechnologies in Medicine: a driver of bioeconomics and a vector of export development" Vladimir Chekhonin, MD, Deputy President of the Russian Academy of Sciences, Head of the Department of Medical Nanobiotechnology at the Institute of Biomedicine (MBF), spoke about the areas that shape the technological sovereignty of the country:

 

"President Vladimir Putin has repeatedly stated that sovereignty is impossible without fundamental science at the highest level. In this regard, I will outline the key areas. First of all, we are talking about genetic engineering, which makes it possible to edit the genome and endow the body with new properties. Next is synthetic biology, which ensures the systematic creation of microorganisms and fundamentally new biological objects with specified properties. And, of course, microbiological technologies — they determine the development of both the food and pharmaceutical industries today. Virology should be noted separately: almost all modern methods of delivering transgenes to cells are based on adeno-associated viruses and viruses of a different nature. To this should be added nanobiotechnology, a symbiosis of nano— and biotechnologies, which allows combining the achievements of both sciences to obtain fundamentally new results. Finally, there are cell biology and regenerative medicine. It is these areas that shape the technological sovereignty of our country."

The development of these areas is becoming an important tool for ensuring the country's scientific independence and strengthening Russia's position in the global high-tech market.